Vildagliptin/metformin
Vildagliptin/Metformin
Vildagliptin/Metformin (pronunciation: vil-dag-lipt-in/met-for-min) is a combination medication used in the treatment of Type 2 diabetes.
Etymology
The term 'Vildagliptin' is derived from the chemical name 'N-(3-hydroxyadamantan-1-yl)-3-pyridinecarboxamide', while 'Metformin' is derived from the chemical name 'N,N-dimethylimidodicarbonimidic diamide'.
Usage
Vildagliptin/Metformin is used to control high blood sugar in people with Type 2 diabetes. This medication is used when diet and exercise alone does not result in controlled blood sugar levels.
Mechanism of Action
Vildagliptin works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. Metformin, on the other hand, works by decreasing glucose production in the liver and absorption in the intestine while improving insulin sensitivity.
Side Effects
Common side effects of Vildagliptin/Metformin include nausea, vomiting, and diarrhea. More serious side effects may include lactic acidosis, pancreatitis, and heart failure.
Related Terms
External links
- Medical encyclopedia article on Vildagliptin/metformin
- Wikipedia's article - Vildagliptin/metformin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski